These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10049279)

  • 1. Single-dose pharmacokinetics of a pleconaril (VP63843) oral solution in children and adolescents. Pediatric Pharmacology Research Unit Network.
    Kearns GL; Abdel-Rahman SM; James LP; Blowey DL; Marshall JD; Wells TG; Jacobs RF
    Antimicrob Agents Chemother; 1999 Mar; 43(3):634-8. PubMed ID: 10049279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-dose pharmacokinetics of a pleconaril (VP63843) oral solution and effect of food.
    Abdel-Rahman SM; Kearns GL
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2706-9. PubMed ID: 9756781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single dose pharmacokinetics of pleconaril in neonates. Pediatric Pharmacology Research Unit Network.
    Kearns GL; Bradley JS; Jacobs RF; Capparelli EV; James LP; Johnson KM; Abdel-Rahman SM
    Pediatr Infect Dis J; 2000 Sep; 19(9):833-9. PubMed ID: 11001105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single oral dose escalation pharmacokinetics of pleconaril (VP 63843) capsules in adults.
    Abdel-Rahman SM; Kearns GL
    J Clin Pharmacol; 1999 Jun; 39(6):613-8. PubMed ID: 10354965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of oral pleconaril on hepatic cytochrome P450 3A activity in healthy adults using intravenous midazolam as a probe.
    Ma JD; Nafziger AN; Rhodes G; Liu S; Gartung AM; Bertino JS
    J Clin Pharmacol; 2006 Jan; 46(1):103-8. PubMed ID: 16397289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleconaril: a novel antipicornaviral drug.
    Romero JR
    Expert Opin Investig Drugs; 2001 Feb; 10(2):369-79. PubMed ID: 11178348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis.
    Abzug MJ; Cloud G; Bradley J; Sánchez PJ; Romero J; Powell D; Lepow M; Mani C; Capparelli EV; Blount S; Lakeman F; Whitley RJ; Kimberlin DW;
    Pediatr Infect Dis J; 2003 Apr; 22(4):335-41. PubMed ID: 12690273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleconaril, a novel antipicornaviral agent.
    Florea NR; Maglio D; Nicolau DP
    Pharmacotherapy; 2003 Mar; 23(3):339-48. PubMed ID: 12627933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duration of pleconaril effect on cytochrome P450 3A activity in healthy adults using the oral biomarker midazolam.
    Ma JD; Nafziger AN; Rhodes G; Liu S; Bertino JS
    Drug Metab Dispos; 2006 May; 34(5):783-5. PubMed ID: 16467135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amantadine and equine influenza: pharmacology, pharmacokinetics and neurological effects in the horse.
    Rees WA; Harkins JD; Woods WE; Blouin RA; Lu M; Fenger C; Holland RE; Chambers TM; Tobin T
    Equine Vet J; 1997 Mar; 29(2):104-10. PubMed ID: 9104558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefpodoxime pharmacokinetics in children: effect of food.
    Kearns GL; Abdel-Rahman SM; Jacobs RF; Wells TG; Borin MT
    Pediatr Infect Dis J; 1998 Sep; 17(9):799-804. PubMed ID: 9779765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of single-dose and multiple-dose memantine in healthy chinese volunteers using an analytic method of liquid chromatography-tandem mass spectrometry.
    Liu MY; Meng SN; Wu HZ; Wang S; Wei MJ
    Clin Ther; 2008 Apr; 30(4):641-53. PubMed ID: 18498913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and Dialyzability of a Single Oral Dose of Amenamevir, an Anti-Herpes Drug, in Hemodialysis Patients.
    Tsuruoka S; Endo T; Seo M; Hashimoto N
    Adv Ther; 2020 Jul; 37(7):3234-3245. PubMed ID: 32440976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
    Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
    Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose pharmacokinetics of ceftibuten (SCH 39720) in infants and children.
    Kearns GL; Reed MD; Jacobs RF; Ardite M; Yogev RD; Blumer JL
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2078-84. PubMed ID: 1759830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Randomized, Double-Blind, Placebo-Controlled Trial of Pleconaril for the Treatment of Neonates With Enterovirus Sepsis.
    Abzug MJ; Michaels MG; Wald E; Jacobs RF; Romero JR; Sánchez PJ; Wilson G; Krogstad P; Storch GA; Lawrence R; Shelton M; Palmer A; Robinson J; Dennehy P; Sood SK; Cloud G; Jester P; Acosta EP; Whitley R; Kimberlin D;
    J Pediatric Infect Dis Soc; 2016 Mar; 5(1):53-62. PubMed ID: 26407253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omeprazole disposition in children following single-dose administration.
    Kearns GL; Andersson T; James LP; Gaedigk A; Kraynak RA; Abdel-Rahman SM; Ramabadran K; van den Anker JN
    J Clin Pharmacol; 2003 Aug; 43(8):840-8. PubMed ID: 12953341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind evaluation of the safety and pharmacokinetics of multiple oral once-daily 750-milligram and 1-gram doses of levofloxacin in healthy volunteers.
    Chien SC; Wong FA; Fowler CL; Callery-D'Amico SV; Williams RR; Nayak R; Chow AT
    Antimicrob Agents Chemother; 1998 Apr; 42(4):885-8. PubMed ID: 9559801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral pleconaril treatment of picornavirus-associated viral respiratory illness in adults: efficacy and tolerability in phase II clinical trials.
    Hayden FG; Coats T; Kim K; Hassman HA; Blatter MM; Zhang B; Liu S
    Antivir Ther; 2002 Mar; 7(1):53-65. PubMed ID: 12008788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.